Key points are not available for this paper at this time.
Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing IHC results for patients. We also present ideas for resolving the remaining issues and unmet needs, along with future directions.
Building similarity graph...
Analyzing shared references across papers
Loading...
Masuda et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69dca716a5c75be4cfe534b3 — DOI: https://doi.org/10.1267/ahc.22-00050
Shinobu Masuda
Yoko Nakanishi
ACTA HISTOCHEMICA ET CYTOCHEMICA
Nihon University
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: